Abstract
Lung cancer, a common malignancy in Taiwan, involves multiple factors, including genetics and environmental factors. The survival time is very short once cancer is diagnosed as being in advanced stage and surgically unresectable. Therefore, a good model of prediction of disease outcome is important for a treatment plan. We investigated the survival time in advanced lung cancer by using computer science from the genetic polymorphism of the p21 and p53 genes in conjunction with patients' general data. We studied 75 advanced and surgical unresectable lung cancer patients. The prediction of survival time was made by comparing real data obtained from follow‐up periods with data generated by an artificial neural network (ANN). The most important input variable was the clinical staging of lung cancer patients. The second and third most important variables were pathological type and responsiveness to treatment, respectively. There were 25 neurons in the input layer, four neurons in the hidden layer‐1, and one neuron in the output layer. The predicted accuracy was 86.2%. The average survival time was 12.44 ± 7.95 months according to real data and 13.16 ± 1.77 months based on the ANN results. ANN provides good prediction results when clinical parameters and genetic polymorphisms are considered in the model. It is possible to use computer science to integrate the genetic polymorphisms and clinical parameters in the prediction of disease outcome. Data mining provides a promising approach to the study of genetic markers for advanced lung cancer. J. Clin. Lab. Anal. 17:229–234, 2003. © 2003 Wiley‐Liss, Inc.
Keywords: artificial neural networks, data mining, lung cancer, p21 gene, p53 gene, survival
REFERENCES
- 1. Department of Health, the Executive Yuan. Republic of China, general health statistics , 1997. In: Health and vital statistics. Taipei, Taiwan: R.O.C. Press; 1998. p 86–108. [Google Scholar]
- 2. Finne P, Finne R, Stenman UH. Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques. BJU Int 2001;88:825–831. [DOI] [PubMed] [Google Scholar]
- 3. Lin JS, Ligomenides PA, Freedman MT, et al. Application of artificial neural networks for reduction of false‐positive detections in digital chest radiographs. Proc Annu Symp Comput Appl Med Care 1993;:434–438. [PMC free article] [PubMed] [Google Scholar]
- 4. Wu YC, Doi K, Giger ML, et al. Reduction of false positives in computerized detection of lung nodules in chest radiographs using artificial neural networks, discriminant analysis, and a rule‐based scheme. J Digit Imaging 1994;7:196–207. [DOI] [PubMed] [Google Scholar]
- 5. Biganzoli E, Boracchi P, Mariani L, et al. Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. Stat Med 1998;17:1169–1186. [DOI] [PubMed] [Google Scholar]
- 6. Loder N. Genetic variations can point the way to disease gene. Nature 1999;401:734. [DOI] [PubMed] [Google Scholar]
- 7. Shih CM, Lin PT, Wang HC, et al. Lack of evidence of association of p21 WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. JPN J Cancer Res 2000;91:9–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Wang YC, Chen CY, Chen SK, et al. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 1999;5:129–134. [PubMed] [Google Scholar]
- 9. Wang YC, Lee HS, Chen SK, et al. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 1999;35:226–230. [DOI] [PubMed] [Google Scholar]
- 10. Anonymous. The world health organization . Histological typing of lung tumors. Neoplasia 1982;29:111–123. [PubMed] [Google Scholar]
- 11. Moutain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710–1717. [DOI] [PubMed] [Google Scholar]
- 12. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus‐associated cancer. Nature 1998;393:229–234. [DOI] [PubMed] [Google Scholar]
- 13. Li YJ, Laurent‐Puig P, Salmon RJ, et al. Polymorphisms and probable lack of mutation in the WAF1‐CIP1 gene in colorectal cancer. Oncogene 1995;10:599–601. [PubMed] [Google Scholar]
- 14. Abratt RP, Sandler A, Crino L. Combined cisplatin and gemcitabine for NSCLC: influence of scheduling on toxicity and drug delivery. Semin Oncol 1998;25(suppl):35–43. [PubMed] [Google Scholar]
- 15. Treat J. Part II: treatment of non‐small cell lung cancer: chemotherapy In: Fishman AP, Elias JA, Fishman JA, et al., editors. Fishman's pulmonary diseases and disorders, Vol. II, 3rd ed. New York: McGraw‐Hill; 1998; p 1797–1818. [Google Scholar]
- 16. SPSS Data Mining . 1998. http://www.spss.com/datamine/whitpap.htm.
- 17. Binder M, Steiner A, Schwarz M, et al. Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. Br J Dermatol 1994;130:460–465. [DOI] [PubMed] [Google Scholar]
- 18. de Tommaso M, Sciruicchio V, Bellotti R, et al. Photic driving response in primary headache: diagnostic value tested by discriminant analysis and artificial neural network classifiers. Ital J Neurol Sci 1999;20:23–28. [DOI] [PubMed] [Google Scholar]
- 19. Mobley BA, Schechter E, Moore WE, et al. Predictions of coronary artery stenosis by artificial neural network. Artif Intell Med 2000;18:187–203. [DOI] [PubMed] [Google Scholar]
- 20. Cho SJ, Hermsmeier MA. Genetic algorithm guided selection: variable selection and subset selection. J Chem Inf Comput Sci 2002;42:927–936. [DOI] [PubMed] [Google Scholar]
- 21. Matsuki Y, Nakamura K, Watanabe H, et al. Usefulness of an artificial neural network for differentiating benign from malignant pulmonary nodules on high resolution CT: evaluation with receiver operating characteristics analysis. AJR Am J Roentgenol 2002;178:657–663. [DOI] [PubMed] [Google Scholar]
- 22. Zhou ZH, Jiang Y, Yang YB, et al. Lung cancer cell identification based on artificial neural network ensembles. Artif Intell Med 2002;24:25–36. [DOI] [PubMed] [Google Scholar]